Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001470831-25-000366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-24 | 2025-11-20 | BBIO | Kumar Neil | CEO, Dir | S - Sale | $65.84 | -26.2K | 234.2K | -10% | -$1.72M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | S | D | 6,401 | $64.97 | 248,531 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $64.49 to $65.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-11-20 | S | D | 5,456 | $66.71 | 228,776 | D | — | — | (F4) Represents the weighted average sale price of the shares sold from $66.49 to $67.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-11-20 | S | D | 14,299 | $65.90 | 234,232 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $65.49 to $66.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |